Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Bergman

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|June 11, 1999
Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell linesC J van Moorsel, H M Pinedo, G Veerman, et al.
Seminars in Oncology|October 1, 1996
Preclinical combination therapy with gemcitabine and mechanisms of resistanceG J Peters, V W Ruiz van Haperen, A M Bergman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 5, 2013
Response to induction chemotherapy and surgery in non-organ confined bladder cancer: a single institution experienceR P Meijer, J A Nieuwenhuijzen, W Meinhardt, et al.
Oncogene|September 20, 2017
Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesisS Stelloo, E Nevedomskaya, Y Kim, et al.
Advances in Experimental Medicine and Biology|January 11, 2002
The role of deoxycytidine kinase in gemcitabine cytotoxicityC L van der Wilt, J R Kroep, A M Bergman, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 2, 2004
Antiproliferative activity and mechanism of action of fatty acid derivatives of gemcitabine in leukemia and solid tumor cell lines and in human xenograftsA M Bergman, C M Kuiper, P Noordhuis, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 2022
Validation of the Prognostic Utility of ESTRO/EORTC Oligometastatic Disease Classification: A Secondary Analysis From the Population-Based Phase II SABR-5 TrialS Baker, B Mou, W Jiang, et al.
Clinical Genitourinary Cancer|January 21, 2024
Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel MonotherapyK van der Zande, R D Tutuhatunewa-Louhanepessy, P Hamberg, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2015
The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancerR J van Soest, A J M Nieuweboer, E S de Morrée, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2008
Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizerJ Sigmond, R J Honeywell, T J Postma, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|June 11, 1999
Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell linesC J van Moorsel, H M Pinedo, G Veerman, et al.
Seminars in Oncology|October 1, 1996
Preclinical combination therapy with gemcitabine and mechanisms of resistanceG J Peters, V W Ruiz van Haperen, A M Bergman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 5, 2013
Response to induction chemotherapy and surgery in non-organ confined bladder cancer: a single institution experienceR P Meijer, J A Nieuwenhuijzen, W Meinhardt, et al.
Oncogene|September 20, 2017
Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesisS Stelloo, E Nevedomskaya, Y Kim, et al.
Advances in Experimental Medicine and Biology|January 11, 2002
The role of deoxycytidine kinase in gemcitabine cytotoxicityC L van der Wilt, J R Kroep, A M Bergman, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 2, 2004
Antiproliferative activity and mechanism of action of fatty acid derivatives of gemcitabine in leukemia and solid tumor cell lines and in human xenograftsA M Bergman, C M Kuiper, P Noordhuis, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 2022
Validation of the Prognostic Utility of ESTRO/EORTC Oligometastatic Disease Classification: A Secondary Analysis From the Population-Based Phase II SABR-5 TrialS Baker, B Mou, W Jiang, et al.
Clinical Genitourinary Cancer|January 21, 2024
Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel MonotherapyK van der Zande, R D Tutuhatunewa-Louhanepessy, P Hamberg, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2015
The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancerR J van Soest, A J M Nieuweboer, E S de Morrée, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2008
Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizerJ Sigmond, R J Honeywell, T J Postma, et al.
Pageof 5